Goodwin Advises Moelis & Company on CorMedix’s $150 Million Convertible Debt Financing
Goodwin Procter LLP represented Moelis & Company LLC, the exclusive placement agent for CorMedix Inc. in an offering of $150 million aggregate principal amount of convertible notes, which partially financed CorMedix’s $300 million acquisition of Melinta Therapeutics LLC.